About KVRC

Main tasks of KVRC

Main tasks of KVRC

Supporting efficacy evaluation to lower technical entry barriers to vaccine development
- To establish evaluation methods for evaluating the efficacy of vaccine candidates and to support testing and analysis including development of reference materials

2022

Revision of the Enforcement Rules of the Infectious Disease Control and Prevention Act (3.22)
Article 5-4 (Testing and analysis on development of infectious disease treatments and vaccines)

2021

Approved animal-use at the biosafety level 3 research facility (ABL3) in the efficacy evaluation building

5 breeding rooms, 2 autopsy rooms, 6 analysis rooms, etc. 713m2 (216 pyeong)

Center for Vaccine Research has completed the certification of the Sample analysis in clinical trials Institute (GCLP, Good Clinical Laboratory Practice).

Completed the National Culture Collection for Pathogens (NCCP)

1 building, total floor area of 5,137m2 (1,554 pyeong)

2020

Established Center for Vaccine Research in National Institute of Infectious Diseases, National Institute of Health (4 departments)

Completed Center for Vaccine Research

2 building, total floor area of 8,490m2 (2,568 pyeong)

2019

Began construction of the National Culture Collection for Pathogens (NCCP), Project cost KRW 19.6 billion

2018

Completed designing Center for Vaccine Research

Groundbreaking ceremony of Center for Vaccine Research

2017

Started Basic and detailed design of Center for Vaccine Research

Enacted and enforced 「Act on Promotion of Collection, Management, and Utilization of Pathogen Resources」

2015

Center for Vaccine Research passed preliminary feasibility study, promoted the project with a total project cost of KRW 67.7 billion

2013

Formed the "Vaccine Industrialization Planning Team" jointly with government ministries and the public and private sectors, promoted "Measures to Enter Global Vaccine Industry", and adopted it as the main agenda of the "National Policy Coordination Meeting [2013]" chaired by the Prime Minister

2012

Promoted the establishment of ‘Center for Vaccine Research’

Established the pathogen resource management TF, designated/announced it as a deposit registration and preservation organization

2011

Signed an MOU for pathogen resource exchange and cooperation with Deutsche Sammlung von Mikroorganismen und Zellkulturen(DSMZ) in Germany

2009

Heightened social demand for ‘vaccine sovereignty’ after the swine flu pandemic

Established Vaccine Research Division in the Infectious Disease Research Center, National Institute of Health, Korea Centers for Disease Control and Prevention, to secure public vaccine technology and to support its development